The Cardiovascular, Respiratory and Metabolic teams at MPR are among the most highly skilled across all indications offering decades of experience providing knowledge in the ever-changing regulatory landscape and cutting-edge solutions to clinical trials in these areas. We have a proven track record of success and maintain adaptability to address the specific needs of every client and trial.

 

​

Cardiovascular

​

What we offer

​

• Proactive and extensive planning of cardiovascular studies for drugs and devices

  • Unrivaled risk assessment stemming from experience

  • Budget and operational planning

• Oversight of project safety from beginning to conclusion of trial

• Seamless integration with projects of similar indication

 

Why MPR?

​

• Successfully completed hundred of studies phases I-IV utilizing both drugs and medical devices:

  • Participation in dozens of countries

  • Contributed to several cardiovascular NDAs

  • Studies including acute care setting, observational and investigational, drug/device combinations and thorough QT

 

​

Respiratory

 

What we offer

​

• Comprehensive CRO services from planning to operational management for studies addressing both common and rare respiratory diseases such as:

  • Acute Bronchitis

  • Allergic Rhinitis

  • Asthma

  • Primary Ciliary Dyskinesia (PCD)

  • Pulmonary Arterial Hypertension (PAH)

  • Many others

• Capabilities to perform all necessary respiratory evaluations and have experts on staff to interpret results and access the data

  • Exercise tests

  • Fractional exhaled nitric oxide (FeNo)

  • Pulmonary function tests (PFTs)

  • Plethysmography

  • Sputum induction

  • Many others

 

Why MPR?

​

• Specialized respiratory expert consortium dedicated to conducting thorough and comprehensive clinical studies

• Proven track record of successful trials for drug and device studies, including respiratory disorders involving adult, neonatal and pediatric indications

 

​

Metabolic

 

What we offer

​

• Vast experience in array of endocrine and metabolic disorders including 

  • Diabetes

  • Obesity

  • Dyslipidemia

  • Metabolic syndrome

  • Many others

• Access to patient populations where these disorders are highly prevalent such as the United States, Eastern Europe, India and South America

• Expertise in managing complex clinical studies common to these disorders and ensuring positive outcomes for patients and trials

 

Why MPR?

​

• Proven track record of conducting successful trials for drug studies

• Innovative solutions for even the most demanding of clinical trials

• Flexible and adaptable with access to diverse patient population